Business / Finance

RSS

3SBio first quarter total net revenues increase 24.5% to RMB147.2M

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced its unaudited financial results for the first quarter ended March 31, 2012.

14 May 2012

Viewpoints: Two views on how to fight obesity; Tough choices for big business on health costs

Forgive us if we don't cheer at the prospect of adding 32 million to the total number of Americans who are dozens of pounds too heavy, a count that stood in 2010 at 78 million.

11 May 2012

Cigna to increase supplemental health insurance offerings with acquisition

Cigna plans to acquire a supplemental health insurance unit from American Financial Group for $295 million to increase its Medicare and other supplemental insurance offerings.

11 May 2012

N.J. Gov. vetoes bill creating health insurance exchange

Gov. Chris Christie, a Republican who is often rumored as a possible running mate for GOP presidential candidate Mitt Romney, said the state should wait to see how the Supreme Court rules on the federal health law.

11 May 2012

IASIS Healthcare second quarter net revenue up 3.8% to $647.6M

IASIS Healthcare LLC today announced financial and operating results for the fiscal second quarter and six months ended March 31, 2012. In the first quarter of 2012, IASIS adopted accounting guidance that results in the classification of the provision for bad debts as a revenue deduction rather than an operating expense, and such guidance has been applied to the financial statements of both the current and prior year periods.

11 May 2012

Osiris Therapeutics first quarter total revenues decrease to $4.6M

Osiris Therapeutics, Inc., the leading stem cell company focused on developing and commercializing products to treat medical conditions in inflammatory, cardiovascular, orthopedic, and wound healing markets, announced today its results for the first quarter ended March 31, 2012.

11 May 2012

Hooper Holmes first quarter consolidated revenues decline 4% to $38.8M

Hooper Holmes today announced financial results for the quarter ended March 31, 2012.

11 May 2012

Accretive readies response after query about latest business practices from Sen. Franken

Health care consultant group Accretive plans to answer questions from the Minnesota senator and respond to the state's attorney general in a report to be released today.

11 May 2012

Northstar Healthcare reports $0.6M net loss for first quarter 2012

Northstar Healthcare Inc. today announced its financial results for the three months ended March 31, 2012. All dollar amounts are in United States currency unless otherwise stated; percentage calculations are based on the numbers in the financial statements and may not correspond to rounded figures presented in this release.

11 May 2012

Aradigm first quarter total revenue increases to $0.3 million

Aradigm Corporation today announced financial results for the first quarter and three months ended March 31, 2012.

11 May 2012

PROLOR Biotech prices underwritten public offering of common stock

PROLOR Biotech, Inc., today announced the pricing of its previously announced underwritten public offering of 6.5 million shares of its common stock at a price to the public of $5.00 per share.

11 May 2012

Helix BioMedix first quarter revenue up 90% to $680,000

Helix BioMedix, Inc., a developer of bioactive peptides, today announced financial results for the first quarter ended March 31, 2012.

11 May 2012

iMedX acquires Accumed

iMedX Inc., a leading healthcare software and services company, announced today that it has completed the acquisition of the assets of Accumed Script Inc. With this acquisition, iMedX adds Accumed's many clinics in Ohio to its customer base.

11 May 2012

Eisai, Arena announce expansion of lorcaserin marketing and supply agreement

Arena Pharmaceuticals, Inc. and Eisai Inc. announced today the expansion of the lorcaserin marketing and supply agreement between Arena Pharmaceuticals, Inc.'s wholly owned subsidiary, Arena Pharmaceuticals GmbH, and Eisai Inc. Lorcaserin is an investigational drug candidate intended for weight management.

11 May 2012

BioFuel Energy first quarter net loss increases to $11.1 million

BIOFUEL ENERGY CORP., an ethanol production company, today announced its first quarter 2012 results.

11 May 2012

SXC prices previously announced public offering of common shares

SXC Health Solutions Corp. announced today the pricing of its previously announced public offering of common shares. Under the offering, SXC will sell 5,200,000 of its common shares at a price to the public of $90.60 per share.

11 May 2012

ChromaDex reports total revenues of $1.8 million for first quarter 2012

ChromaDex Corporation an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries, today announced its financial results for the first quarter of 2012.

11 May 2012

Feihe International first quarter revenue decreases to $62.9M

Feihe International, Inc., one of the leading producers and distributors of premium infant formula, milk powder, and soybean, rice and walnut products in China, today announced financial results for the first quarter of 2012.

10 May 2012

Georgia Tech project to design new warehousing and storage system for vaccines, drugs

The Georgia Institute of Technology has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The program funds individuals worldwide to explore ideas that can break the mold in how persistent global health and development challenges are solved.

10 May 2012

Orexigen reports net loss of $10.4 million for first quarter 2012

Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced financial results for the first quarter of 2012.

10 May 2012